Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Role of osteogenic Menin in bone mass accumulation in vivo

EF 2015-16

Résumé
Patients of the Multiple Endocrine Neoplasia type 1 disorder (Men1) present with tumours in endocrine and non-endocrine tissues. These patients have both copies of their Men1 gene mutated, and hence a non-functional protein product called menin.Mice generated to lack menin in all of their cells die before they are born, and exhibit deformations in their developing skulls. This alluded to the involvement of menin not only in cancer genetics and endocrinology, but also in bone development. Understanding its role in the later can give insight onto its potential use in the clinic as a gain-of-function therapeutic target for patients with low bone mass disorders.Preliminary studies have given us insight onto the functionality of this protein both in cultured cells at the molecular level, and in mice as a whole. When the protein is knocked out only in mature bone cells, mice present with significant impairment of bone micro- and macro- structure, bone mineral density and bone growth. In this study, we aim to knock out menin in the stem cells that give rise to the mature bone cells previously studied; this will help us understand how this protein works in directing precursors into the osteogenic lineage, and will be an essential step to take before we can start investigating drugs that can augment its activity. Analysis of bones will include DXA, micro-CT and histomorphometry, while several in-vitro functional assays will be performed on extracted skull bone cells as well.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
350176
Name
Abi Rafeh Jad
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of osteogenic Menin in bone mass accumulation in vivo
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bone; Bone Morphogenic Protein-2 (Bmp-2); Gene Knockout; Menin; Mesenchymal Stem Cell; Mouse; Osteoblast; Osteoclast; Osteoporosis; Transforming Growth Factor-B (Tgf-B)
Abstract
Patients of the Multiple Endocrine Neoplasia type 1 disorder (Men1) present with tumours in endocrine and non-endocrine tissues. These patients have both copies of their Men1 gene mutated, and hence a non-functional protein product called menin.Mice generated to lack menin in all of their cells die before they are born, and exhibit deformations in their developing skulls. This alluded to the involvement of menin not only in cancer genetics and endocrinology, but also in bone development. Understanding its role in the later can give insight onto its potential use in the clinic as a gain-of-function therapeutic target for patients with low bone mass disorders.Preliminary studies have given us insight onto the functionality of this protein both in cultured cells at the molecular level, and in mice as a whole. When the protein is knocked out only in mature bone cells, mice present with significant impairment of bone micro- and macro- structure, bone mineral density and bone growth. In this study, we aim to knock out menin in the stem cells that give rise to the mature bone cells previously studied; this will help us understand how this protein works in directing precursors into the osteogenic lineage, and will be an essential step to take before we can start investigating drugs that can augment its activity. Analysis of bones will include DXA, micro-CT and histomorphometry, while several in-vitro functional assays will be performed on extracted skull bone cells as well.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Abi Rafeh, Jad
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~